Biofrontera Inc. Investment Income, Interest
Biofrontera Inc. (BFRI) reported Investment Income, Interest of $14.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2025-05-15
- Biofrontera Inc. investment income, interest for the quarter ending 2025-03-31 was $14.00K, a 0.00% change year-over-year.
- Biofrontera Inc. investment income, interest for the quarter ending 2024-12-31 was $15.00K, a 28.57% decline year-over-year.
- Biofrontera Inc. investment income, interest for the quarter ending 2024-09-30 was $17.00K, a 30.77% increase year-over-year.
- Biofrontera Inc. investment income, interest for the quarter ending 2024-03-31 was $14.00K.
- Biofrontera Inc. investment income, interest for fiscal 2024 was $71.00K, a 46.21% decline from fiscal 2023.
- Biofrontera Inc. investment income, interest for fiscal 2023 was $132.00K.
- Biofrontera Inc. investment income, interest for fiscal 2021 was $16.00K, a 42.86% decline from fiscal 2020.
- Biofrontera Inc. investment income, interest for fiscal 2020 was $28.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2025-03-31 | $14.00K 10-Q · filed 2025-05-15 | $29.00K derived: sum of 2 quarters · filed 2025-05-15 | $46.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $32.00K derived: sum of 2 quarters · filed 2025-03-20 | $71.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $17.00K 10-Q · filed 2024-11-14 | $56.00K 10-Q · filed 2024-11-14 | ||
| 2024-03-31 | $14.00K 10-Q · filed 2025-05-15 | $35.00K derived: sum of 2 quarters · filed 2025-05-15 | $48.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $34.00K derived: sum of 2 quarters · filed 2025-03-20 | $132.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $13.00K 10-Q · filed 2024-11-14 | $111.00K 10-Q · filed 2024-11-14 | ||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $7.00K derived: sum of 2 quarters · filed 2022-04-11 | $16.00K 10-K · filed 2022-04-11 | |
| 2021-09-30 | $4.00K 10-Q · filed 2021-11-30 | $13.00K 10-Q · filed 2021-11-30 | ||
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $12.00K derived: sum of 2 quarters · filed 2022-04-11 | $28.00K 10-K · filed 2022-04-11 | |
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-30 | $23.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |